News

FDA addressing risk of cyberattacks on medical devices


 

The Food and Drug Administration is encouraging health care professionals –and patients – to report adverse events associated with medical devices, as part of an effort to address the potential for cyberattacks on medical equipment and medical devices, including implanted medical devices.

The agency has become aware of "cybersecurity vulnerabilities and incidents that could directly affect medical devices or hospital network operations," according to a statement on the FDA’s MedWatch site.

The statement adds, however, that the FDA "is not aware of any patient injuries or deaths associated with these incidents nor do we have any indication that any specific devices or systems in clinical use have been purposely targeted at this time."

The FDA is working with manufacturers and other federal agencies to address this issue. The agency has recommended that manufacturers and health care facilities institute safeguards to reduce the risk of medical device failures caused by a cyberattack, including evaluating network security at hospitals and health care facilities. Efforts include draft guidance for industry and FDA staff.

Adverse events associated with devices should be reported to the MedWatch Safety Information and Adverse Event Reporting Program or by calling 800-332-1081.

emechcatie@frontlinemedcom.com

Recommended Reading

HHS fundraising probe expands: The Policy & Practice Podcast
MDedge Internal Medicine
Telaprevir-based triple-drug therapy benefits CHC patients with ESRD
MDedge Internal Medicine
New HIPAA requirements
MDedge Internal Medicine
Medicare uses more brand-name drugs than does VA
MDedge Internal Medicine
Feds back down on emergency contraception
MDedge Internal Medicine
Drug shortages affect prescribing for 83% of oncologists
MDedge Internal Medicine
Supreme Court: Human genes cannot be patented
MDedge Internal Medicine
Report: Retail clinic growth to be driven by physician partnerships
MDedge Internal Medicine
Workplace wellness programs: Helpful or burdensome?
MDedge Internal Medicine
Supreme Court allows FTC to challenge 'pay for delay' settlements
MDedge Internal Medicine